Unknown

Dataset Information

0

Somatic V600E BRAF Mutation in Linear and Sporadic Syringocystadenoma Papilliferum.

ABSTRACT:

SUBMITTER: Levinsohn JL 

PROVIDER: S-EPMC4567902 | biostudies-literature | 2015 Oct

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Somatic V600E BRAF Mutation in Linear and Sporadic Syringocystadenoma Papilliferum.

Levinsohn Jonathan L JL   Sugarman Jeffrey L JL   Bilguvar Kaya K   McNiff Jennifer M JM   Choate Keith A KA   The Yale Center For Mendelian Genomics  

The Journal of investigative dermatology 20150507 10

Similar Datasets

Unknown Location based BRAF V600E mutation status and dimension patterns of sporadic thyroid nodules: a population-based study.
| S-EPMC11884127 | biostudies-literature
Unknown Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors.
| S-EPMC4826187 | biostudies-literature
Unknown Improved survival with vemurafenib in melanoma with BRAF V600E mutation.
| S-EPMC3549296 | biostudies-literature
Unknown BRAF V600E mutation detected in a case of Rosai-Dorfman disease.
| S-EPMC6068029 | biostudies-literature
Unknown Identification of a Novel Non-V600E BRAF Mutation in Papillary Thyroid Cancer.
| S-EPMC10965284 | biostudies-literature
Unknown Colon metastasis from lung adenocarcinoma with BRAF V600E mutation: A case report.
| S-EPMC9393296 | biostudies-literature
Unknown Clinical utility of a blood-based BRAF(V600E) mutation assay in melanoma.
| S-EPMC4258469 | biostudies-literature
Unknown Acquired Secondary RAS Mutation in BRAF<sup>V600E</sup>-Mutated Thyroid Cancer Patients Treated with BRAF Inhibitors.
| S-EPMC7869871 | biostudies-literature
Unknown VE1 immunohistochemistry predicts BRAF V600E mutation status and clinical outcome in colorectal cancer.
| S-EPMC4747166 | biostudies-literature
Unknown <i>BRAF</i> V600E Mutation in Ameloblastoma: A Systematic Review and Meta-Analysis.
| S-EPMC9688909 | biostudies-literature